IL33 and asthma: In contrast to the primary pathogenic role of 12/15-LOX in asthma, IL-33 administration to Alox15−/− mice results in augmented airway inflammation, suggesting that 12/15-LOX expression is required to limit IL-33-mediated airway inflammation.